The Role of Single-Subject Brain Metabolic Patterns in the Early Differential Diagnosis of Primary Progressive Aphasias and in Prediction of Progression to Dementia

Autor: Alessandra Marcone, Giuseppe Magnani, Daniela Perani, Elisabetta Pelagallo, Stefano F. Cappa, Roberto Santangelo, Alessandra Dodich, Sandro Iannaccone, Chiara Cerami, Lucia Greco
Přispěvatelé: Cerami, C., Dodich, A., Greco, L., Iannaccone, S., Magnani, G., Marcone, A., Pelagallo, E., Santangelo, R., Cappa, STEFANO FRANCESCO, Perani, DANIELA FELICITA L.
Rok vydání: 2016
Předmět:
Male
0301 basic medicine
positron emission tomography
non fluent variant of primary progressive aphasia
Aphasiology
Neuropsychological Tests
Primary progressive aphasia
Cognition
0302 clinical medicine
Corticobasal degeneration
logopenic variant of primary progressive aphasia
Precision Medicine
FDG-PET
Anarthria
biology
General Neuroscience
Brain
General Medicine
respiratory system
Psychiatry and Mental health
Clinical Psychology
Disease Progression
Female
Research Article
Frontotemporal dementia
semantic variant of primary progressive aphasia
Progressive supranuclear palsy
Diagnosis
Differential

03 medical and health sciences
Fluorodeoxyglucose F18
medicine
Humans
Dementia
Aged
Retrospective Studies
business.industry
medicine.disease
biology.organism_classification
Aphasia
Primary Progressive

Early Diagnosis
030104 developmental biology
Positron-Emission Tomography
primary progressive aphasia
Radiopharmaceuticals
Geriatrics and Gerontology
Differential diagnosis
business
Neuroscience
030217 neurology & neurosurgery
Follow-Up Studies
Zdroj: Journal of Alzheimer's Disease
ISSN: 1875-8908
1387-2877
Popis: Background and Objective: Primary progressive aphasia (PPA) is a clinical syndrome due to different neurodegenerative conditions in which an accurate early diagnosis needs to be supported by a reliable diagnostic tool at the individual level. In this study, we investigated in PPA the FDG-PET brain metabolic patterns at the single-subject level, in order to assess the case-to-case variability and its relationship with clinical-neuropsychological findings. Material and Methods: 55 patients (i.e., 11 semantic variant/sv-PPA, 19 non fluent variant/nfv-PPA, 17 logopenic variant/lv-PPA, 3 slowly progressive anarthria/SPA, and 5 mixed PPA/m-PPA) were included. Clinical-neuropsychological information and FDG-PET data were acquired at baseline. A follow-up of 27.4±12.55 months evaluated the clinical progression. Brain metabolism was analyzed using an optimized and validated voxel-based SPM method at the single-subject level. Results: FDG-PET voxel-wise metabolic assessment revealed specific metabolic signatures characterizing each PPA variant at the individual level, reflecting the underlying neurodegeneration in language networks. Notably, additional dysfunctional patterns predicted clinical progression to specific dementia conditions. In the case of nfv-PPA, a metabolic pattern characterized by involvement of parietal, subcortical and brainstem structures predicted progression to a corticobasal degeneration syndrome or to progressive supranuclear palsy. lv-PPA and sv-PPA cases who progressed to Alzheimer’s disease and frontotemporal dementia at the follow-up presented with extended bilateral patterns at baseline. Discussion: Our results indicate that FDG-PET voxel-wise imaging is a valid biomarker for the early differential diagnosis of PPAs and for the prediction of progression to specific dementia condition. This study supports the use of FDG-PET imaging quantitative assessment in clinical settings for a better characterization of PPA individuals and prognostic definition of possible endo-phenotypes.
Databáze: OpenAIRE